izpis_h1_title_alt

Mucoadhesive film for oral delivery of vaccines for protection of the respiratory tract
ID Esih, Hana (Author), ID Mezgec, Klemen (Author), ID Malenšek, Špela (Author), ID Grilc, Blaž (Author), ID Vidmar, Sara (Author), ID Gašperlin, Mirjana (Author), ID Lainšček, Duško (Author), ID Jerala, Roman (Author), et al.

.pdfPDF - Presentation file, Download (3,31 MB)
MD5: 626B010FF79633B32924FE320B52DC01
URLURL - Source URL, Visit https://www.sciencedirect.com/science/article/pii/S0168365924003262 This link opens in a new window

Abstract
The delivery of vaccines plays a pivotal role in influencing the strength and longevity of the immune response and controlling reactogenicity. Mucosal immunization, as compared to parenteral vaccination, could offer greater protection against respiratory infections while being less invasive. While oral vaccination has been presumed less effective and believed to target mainly the gastrointestinal tract, trans-buccal delivery using mucoadhesive films (MAF) may allow targeted delivery to the mucosa. Here we present an effective strategy for mucosal delivery of several vaccine platforms incorporated in MAF, including DNA plasmids, viral vectors, and lipid nanoparticles incorporating mRNA (mRNA/LNP). The mRNA/LNP vaccine formulation targeting SARS-CoV-2 as a proof of concept remained stable within MAF consisting of slowly releasing water-soluble polymers and an impermeable backing layer, facilitating enhanced penetration into the oral mucosa. This formulation elicited antibody and cellular responses comparable to the intramuscular injection, but also induced the production of mucosal IgAs, highlighting its efficacy, particularly for use as a booster vaccine and the potential advantage for protection against respiratory infections. The MAF vaccine preparation demonstrates significant advantages, such as efficient delivery, stability, and simple noninvasive administration with the potential to alleviate vaccine hesitancy.

Language:English
Keywords:vaccine delivery, mucoadhesive film, mucosal immunity, respiratory infection
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2024
Number of pages:Str. 179-192
Numbering:Vol. 371
PID:20.500.12556/RUL-158412 This link opens in a new window
UDC:615.371
ISSN on article:0168-3659
DOI:10.1016/j.jconrel.2024.05.041 This link opens in a new window
COBISS.SI-ID:197189635 This link opens in a new window
Publication date in RUL:07.06.2024
Views:195
Downloads:38
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Journal of controlled release
Shortened title:J. control. release
Publisher:Elsevier
ISSN:0168-3659
COBISS.SI-ID:27318784 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:dostava cepiv, mukoadhezivni film, imuniteta sluznice, okužba dihal, sproščanje, erozija, imunski odziv, dostavni sistemi, cepiva

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P4-0176
Name:Sintezna biologija in imunologija

Funder:ARRS - Slovenian Research Agency
Project number:P3-0289
Name:Značilnosti malignih neoplazem, pomembne za diagnozo ter napoved poteka bolezni in izida zdravljenja

Funder:EC - European Commission
Funding programme:H2020
Project number:899619
Name:General-purpose virus-neutralizing engulfing shells with modular target-specificity
Acronym:VIROFIGHT

Funder:EC - European Commission
Funding programme:HE
Project number:101059842
Name:Centre of Excellence for the Technologies of Gene and Cell Therapy
Acronym:CTGCT

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-4526
Name:Himerna avtologna vakcina proti PCSK9

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J7-4493
Name:Mikrofluidična mehanoporacija za celično terapijo

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back